Motivational abnormalities are core deficits in several mental disorders including schizophrenia, depression, and drug addiction. To develop more effective therapeutic strategies for these deficits the underlying molecular mechanisms and the relevant changes in neuronal function and circuitry have to be identified. The long-term goal of this project is to understand the causal relationship between altered excitability of striatal principal neurons called medium spiny neurons (MSN) and motivational deficits. Specifically, the project proposes to take advantage of a genetic mouse model of dopamine D2 receptor up-regulation in MSNs that is associated with a deficit in motivation. The main hypothesis of the application is that increased density of D2Rs in the striatum leads to motivational deficits by increasing the excitability of one class of MSNs, the striato-pallidal neurons.
Two specific aims will address this hypothesis:
Aim 1 : To test the hypothesis that D2R up-regulation increases MSN excitability Aim 2: To test the hypothesis that MSN excitability is a key regulator of motivational behavior.
The specific aims will be completed by combining mouse genetics with behavioral and electrophysiological studies. MSN excitability will be altered selectively in the striato-pallidal pathway of the striatum using virally mediated expression of ion channels.

Public Health Relevance

Motivational abnormalities are core deficits in several mental disorders, but the underlying molecular mechanisms and the changes in neuronal function and circuitry have still to be identified. Studying whether altered excitability of striatal neurons leads to motivational impairments will help to understand the neuronal mechanisms that underlie motivation and could guide the development of new medication for psychiatric diseases.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Neurobiology of Motivated Behavior Study Section (NMB)
Program Officer
Winsky, Lois M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Schools of Medicine
New York
United States
Zip Code
Canetta, Sarah; Kellendonk, Christoph (2018) Can we use mice to study schizophrenia? Philos Trans R Soc Lond B Biol Sci 373:
Gallo, Eduardo F; Meszaros, Jozsef; Sherman, Jeremy D et al. (2018) Accumbens dopamine D2 receptors increase motivation by decreasing inhibitory transmission to the ventral pallidum. Nat Commun 9:1086
Donthamsetti, Prashant; Gallo, Eduardo F; Buck, David C et al. (2018) Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation. Mol Psychiatry :
Labouesse, Marie A; Sartori, Andrea M; Weinmann, Oliver et al. (2018) Striatal dopamine 2 receptor upregulation during development predisposes to diet-induced obesity by reducing energy output in mice. Proc Natl Acad Sci U S A 115:10493-10498
Clark, Abigail M; Leroy, Felix; Martyniuk, Kelly M et al. (2017) Dopamine D2 Receptors in the Paraventricular Thalamus Attenuate Cocaine Locomotor Sensitization. eNeuro 4:
Simpson, Eleanor H; Kellendonk, Christoph (2017) Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation. Biol Psychiatry 81:21-30
Biezonski, D; Shah, R; Krivko, A et al. (2016) Longitudinal magnetic resonance imaging reveals striatal hypertrophy in a rat model of long-term stimulant treatment. Transl Psychiatry 6:e884
Carvalho Poyraz, Fernanda; Holzner, Eva; Bailey, Matthew R et al. (2016) Decreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action. J Neurosci 36:5988-6001
Bolkan, S S; Carvalho Poyraz, F; Kellendonk, C (2016) Using human brain imaging studies as a guide toward animal models of schizophrenia. Neuroscience 321:77-98
Gallo, Eduardo F; Salling, Michael C; Feng, Bo et al. (2015) Upregulation of dopamine D2 receptors in the nucleus accumbens indirect pathway increases locomotion but does not reduce alcohol consumption. Neuropsychopharmacology 40:1609-18

Showing the most recent 10 out of 17 publications